 | • レポートコード：QFJ1-5929 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・パニツムマブの市場動向 ・企業の競争状況、市場シェア ・パニツムマブの種類別市場規模と予測2016-2027（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル） ・パニツムマブの用途別市場規模と予測2016-2027（病院、ドラッグストア） ・パニツムマブの北米市場規模2016-2027（アメリカ、カナダ） ・パニツムマブの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・パニツムマブのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パニツムマブの中南米市場規模2016-2027（メキシコ、ブラジル） ・パニツムマブの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen） ・結論 |
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).
Market Analysis and Insights: Global Panitumumab Market
The global Panitumumab market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Panitumumab market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Panitumumab market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Panitumumab market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Panitumumab market.
Global Panitumumab Scope and Market Size
Panitumumab market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Panitumumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Panitumumab Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 100 mg/5 mL single-dose vials
1.2.3 400 mg/20 mLsingle-dose vials
1.3 Market by Application
1.3.1 Global Panitumumab Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Panitumumab Market Perspective (2016-2027)
2.2 Panitumumab Growth Trends by Regions
2.2.1 Panitumumab Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Panitumumab Historic Market Share by Regions (2016-2021)
2.2.3 Panitumumab Forecasted Market Size by Regions (2022-2027)
2.3 Panitumumab Industry Dynamic
2.3.1 Panitumumab Market Trends
2.3.2 Panitumumab Market Drivers
2.3.3 Panitumumab Market Challenges
2.3.4 Panitumumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Panitumumab Players by Revenue
3.1.1 Global Top Panitumumab Players by Revenue (2016-2021)
3.1.2 Global Panitumumab Revenue Market Share by Players (2016-2021)
3.2 Global Panitumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Panitumumab Revenue
3.4 Global Panitumumab Market Concentration Ratio
3.4.1 Global Panitumumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Panitumumab Revenue in 2020
3.5 Panitumumab Key Players Head office and Area Served
3.6 Key Players Panitumumab Product Solution and Service
3.7 Date of Enter into Panitumumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Panitumumab Breakdown Data by Type
4.1 Global Panitumumab Historic Market Size by Type (2016-2021)
4.2 Global Panitumumab Forecasted Market Size by Type (2022-2027)
5 Panitumumab Breakdown Data by Application
5.1 Global Panitumumab Historic Market Size by Application (2016-2021)
5.2 Global Panitumumab Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Panitumumab Market Size (2016-2027)
6.2 North America Panitumumab Market Size by Type
6.2.1 North America Panitumumab Market Size by Type (2016-2021)
6.2.2 North America Panitumumab Market Size by Type (2022-2027)
6.2.3 North America Panitumumab Market Size by Type (2016-2027)
6.3 North America Panitumumab Market Size by Application
6.3.1 North America Panitumumab Market Size by Application (2016-2021)
6.3.2 North America Panitumumab Market Size by Application (2022-2027)
6.3.3 North America Panitumumab Market Size by Application (2016-2027)
6.4 North America Panitumumab Market Size by Country
6.4.1 North America Panitumumab Market Size by Country (2016-2021)
6.4.2 North America Panitumumab Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Panitumumab Market Size (2016-2027)
7.2 Europe Panitumumab Market Size by Type
7.2.1 Europe Panitumumab Market Size by Type (2016-2021)
7.2.2 Europe Panitumumab Market Size by Type (2022-2027)
7.2.3 Europe Panitumumab Market Size by Type (2016-2027)
7.3 Europe Panitumumab Market Size by Application
7.3.1 Europe Panitumumab Market Size by Application (2016-2021)
7.3.2 Europe Panitumumab Market Size by Application (2022-2027)
7.3.3 Europe Panitumumab Market Size by Application (2016-2027)
7.4 Europe Panitumumab Market Size by Country
7.4.1 Europe Panitumumab Market Size by Country (2016-2021)
7.4.2 Europe Panitumumab Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Panitumumab Market Size (2016-2027)
8.2 Asia-Pacific Panitumumab Market Size by Type
8.2.1 Asia-Pacific Panitumumab Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Panitumumab Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Panitumumab Market Size by Type (2016-2027)
8.3 Asia-Pacific Panitumumab Market Size by Application
8.3.1 Asia-Pacific Panitumumab Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Panitumumab Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Panitumumab Market Size by Application (2016-2027)
8.4 Asia-Pacific Panitumumab Market Size by Region
8.4.1 Asia-Pacific Panitumumab Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Panitumumab Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Panitumumab Market Size (2016-2027)
9.2 Latin America Panitumumab Market Size by Type
9.2.1 Latin America Panitumumab Market Size by Type (2016-2021)
9.2.2 Latin America Panitumumab Market Size by Type (2022-2027)
9.2.3 Latin America Panitumumab Market Size by Type (2016-2027)
9.3 Latin America Panitumumab Market Size by Application
9.3.1 Latin America Panitumumab Market Size by Application (2016-2021)
9.3.2 Latin America Panitumumab Market Size by Application (2022-2027)
9.3.3 Latin America Panitumumab Market Size by Application (2016-2027)
9.4 Latin America Panitumumab Market Size by Country
9.4.1 Latin America Panitumumab Market Size by Country (2016-2021)
9.4.2 Latin America Panitumumab Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Panitumumab Market Size (2016-2027)
10.2 Middle East & Africa Panitumumab Market Size by Type
10.2.1 Middle East & Africa Panitumumab Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Panitumumab Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Panitumumab Market Size by Type (2016-2027)
10.3 Middle East & Africa Panitumumab Market Size by Application
10.3.1 Middle East & Africa Panitumumab Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Panitumumab Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Panitumumab Market Size by Application (2016-2027)
10.4 Middle East & Africa Panitumumab Market Size by Country
10.4.1 Middle East & Africa Panitumumab Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Panitumumab Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Panitumumab Introduction
11.1.4 Amgen Revenue in Panitumumab Business (2016-2021)
11.1.5 Amgen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Panitumumab Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 100 mg/5 mL single-dose vials
Table 3. Key Players of 400 mg/20 mLsingle-dose vials
Table 4. Global Panitumumab Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Panitumumab Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Panitumumab Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Panitumumab Market Share by Regions (2016-2021)
Table 8. Global Panitumumab Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Panitumumab Market Share by Regions (2022-2027)
Table 10. Panitumumab Market Trends
Table 11. Panitumumab Market Drivers
Table 12. Panitumumab Market Challenges
Table 13. Panitumumab Market Restraints
Table 14. Global Panitumumab Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Panitumumab Market Share by Players (2016-2021)
Table 16. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panitumumab as of 2020)
Table 17. Ranking of Global Top Panitumumab Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Panitumumab Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Panitumumab Product Solution and Service
Table 21. Date of Enter into Panitumumab Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Panitumumab Revenue Market Share by Type (2016-2021)
Table 25. Global Panitumumab Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Panitumumab Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Panitumumab Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Panitumumab Revenue Market Share by Application (2016-2021)
Table 29. Global Panitumumab Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Panitumumab Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Panitumumab Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Panitumumab Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Panitumumab Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Panitumumab Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Panitumumab Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Panitumumab Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Panitumumab Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Panitumumab Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Panitumumab Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Panitumumab Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Panitumumab Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Panitumumab Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Panitumumab Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Panitumumab Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Panitumumab Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Panitumumab Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Panitumumab Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Panitumumab Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Panitumumab Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Panitumumab Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Panitumumab Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Panitumumab Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Panitumumab Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Panitumumab Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Panitumumab Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Panitumumab Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen Panitumumab Product
Table 64. Amgen Revenue in Panitumumab Business (2016-2021) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Panitumumab Market Share by Type: 2020 VS 2027
Figure 2. 100 mg/5 mL single-dose vials Features
Figure 3. 400 mg/20 mLsingle-dose vials Features
Figure 4. Global Panitumumab Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Panitumumab Report Years Considered
Figure 8. Global Panitumumab Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Panitumumab Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Panitumumab Market Share by Regions: 2020 VS 2027
Figure 11. Global Panitumumab Market Share by Regions (2022-2027)
Figure 12. Global Panitumumab Market Share by Players in 2020
Figure 13. Global Top Panitumumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panitumumab as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Panitumumab Revenue in 2020
Figure 15. Global Panitumumab Revenue Market Share by Type (2016-2021)
Figure 16. Global Panitumumab Revenue Market Share by Type (2022-2027)
Figure 17. North America Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Panitumumab Market Share by Type (2016-2027)
Figure 19. North America Panitumumab Market Share by Application (2016-2027)
Figure 20. North America Panitumumab Market Share by Country (2016-2027)
Figure 21. United States Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Panitumumab Market Share by Type (2016-2027)
Figure 25. Europe Panitumumab Market Share by Application (2016-2027)
Figure 26. Europe Panitumumab Market Share by Country (2016-2027)
Figure 27. Germany Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Panitumumab Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Panitumumab Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Panitumumab Market Share by Region (2016-2027)
Figure 37. China Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Panitumumab Market Share by Type (2016-2027)
Figure 45. Latin America Panitumumab Market Share by Application (2016-2027)
Figure 46. Latin America Panitumumab Market Share by Country (2016-2027)
Figure 47. Mexico Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Panitumumab Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Panitumumab Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Panitumumab Market Share by Country (2016-2027)
Figure 53. Turkey Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Panitumumab Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Amgen Revenue Growth Rate in Panitumumab Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
世界の単回照射放射線療法市場規模・現状・予測（2021年-2027年） Single dose radiotherapy has been pitched as an alternative to the conventional radiotherapy for cancer treatment. It has many advantages like less number of visits to the clinic, affordability, less side effects among others. Market Analysis and Insights: Global Single Dose Radiotherapy Market The …- 世界のミルセラ（メトキシポリエチレングリコール-エポエチンベータ）市場規模・現状・予測（2021年-2027年） Mircera (methoxy polyethylene glycol-epoetin beta) is used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD). Market Analysis and Insights: Global Mircera (methoxy polyethylene glycol-epoetin beta) Market The global Mircera (methoxy polyethylene glycol-epoetin b…
- 単位薬剤投与量送達システムのグローバル市場調査 2019年 The global Unit Drug Dose Delivery System market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Unit Drug Dose Delivery System volume and value at global level, regional level and company level. From a gl…
- 単位薬剤投与量送達システムのグローバル市場調査 2019年 The global Unit Drug Dose Delivery System market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Unit Drug Dose Delivery System volume and value at global level, regional level and company level. From a gl…
- 世界のセルトリズマブペゴル市場規模・現状・予測（2021年-2027年） Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Market Analysis and Insights: Global Certolizumab pegol Market The global Certolizumab pegol market size is projected to …